Derek Chalmers - President & CEO, Cara Therapeutics, Inc

As of September 9, 2021


Derek Chalmers Net Worth

  • Net worth is estimated to be at least $53.04M
  • Owns at least 991,405 units of Cara Therapeutics, Inc stock
  • Sold an estimated value of $7.2M in the last 7 years at Cara Therapeutics, Inc

Derek Chalmers Trading

  • Largest purchase of shares was 20,000 units , worth over $49.6K on November 3, 2017
  • Largest sale of shares was 20,000 units , worth over $475.8K on October 3, 2018
  • In total has made about 48 transactions over 7 years
  • Usually trades in December, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Derek Chalmers Mailing Address

  • Mailing address is C/o Cara Therapeutics, Inc. 1 Parrott Drive Shelton CT 06484 CT

Cara Therapeutics, Inc Insider Trading

  • The most recent transaction was 8,180 units sold on November 16, 2021 by Jeffrey Ives worth over $131.21K
  • In the last 7 years, insiders at Cara Therapeutics, Inc sold an estimated value of $26.24M and bought an estimated value of $21.17M
  • The most active traders are Phd Frederique Menzaghi, Chief Scientific OffSVP-R&D,  Derek Chalmers, President & CEO,  and Jeffrey Ives, Director
  • Insider trading is most common in June, with the busiest year in 2020

Cara Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1